A study of ORM-12741 on cognitive and behavioural symptoms such e.g. memory, orientation, learning in patients with Alzheimer’s disease (form of dementia)

Mise à jour : Il y a 5 ans
Référence : EUCTR2010-022922-34

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objectives of the study are to evaluate the safety and tolerability of ORM-12741, and the efficacy of ORM-12741 on cognitive symptoms in patients with Alzheimer’s disease (AD) receiving acetylcholinesterase (AChE) inhibitor therapy.


Critère d'inclusion

  • Alzheimer’s disease (AD)